Medical Device News Magazine

Ethypharm Announces Xavier LASSERRE as the New CCO | Leading Pharmaceutical Veteran

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Denis DELVAL, President & CEO of the Ethypharm Group, announces the appointment of Xavier LASSERRE as Chief Commercial Officer (CCO), effective June 12, 2023.

Xavier LASSERRE has a strong experience and expertise in the pharmaceutical industry, particularly in the European markets, both in the retail and hospital sectors.

He holds an advanced degree in Neuroscience and is a graduate of ESCP (Paris Business School). With over 25 years of experience, he has demonstrated remarkable leadership in various roles, contributing significantly to the success and transformation of businesses under his responsibility. Xavier’s most recent position was as Head of Commercial Operations at Zentiva Group, where he was a valued member of the Executive Committee, overseeing affiliate General Managers and export activities.

Xavier joins the Executive Committee of Ethypharm and leads the company’s head of affiliates UK, China, France, Spain, Germany, and Italy. Additionally, Xavier will oversee the distribution and licenses businesses, as well as the Business Development functions.

“I’ am thrilled to join Ethypharm as the new Chief Commercial Officer. Ethypharm has a strong commitment to improving patient lives, and I am eager, with the talented team at Ethypharm, to contribute to the company’s growth and success. I look forward to leading the commercial strategy, driving market expansion, and fostering collaborations to bring our valuable treatments to more patients worldwide.” Says Xavier LASSERRE.

Denis DELVAL – CEO & President of the Group Ethypharm, expresses confidence in Xavier’s ability to drive the company’s commercial growth and stated, “We are delighted to welcome Xavier to the Ethypharm Group. His extensive experience and proven track record in the pharmaceutical industry make him an ideal fit for our organization. We are confident that Xavier’s commercial talent and expertise combined with his leadership will contribute significantly to our continued success. We are excited about this new chapter and look forward to working together towards achieving our goals and further strengthening our position in the market.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”